Samsung Biologics falls 3% after $1.8 billion PolyPeptide acquisition
Investing.com· Investing.com· Jul 20, 2026 · 4:00 AM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 1 hour ago
Will worries about AI Doom end the AI Boom? BCA answers
Investing.com
stocksabout 1 hour ago
Analyst explains why you should avoid owning Nike stock despite massive pullback
Investing.com
stocksabout 2 hours ago
Weil, Gotshal & Manges eyes merger options after rainmakers exit, Bloomberg News reports
Investing.com